Bacteriophages of pseudomonas aeruginosa: Long-term prospects for use in phage therapy

Advances in Virus Research

Volumn 88, Issue , 2014, Pages 227-278

  Krylov, Victor N ^a  

^a MECHNIKOV RESEARCH INSTITUTE FOR VACCINES AND SERA   (Russian Federation)

Author keywords

Interspecies phage migrations; Phage therapy; Pseudomonas aeruginosa bacteriophages; Species of transposable Pseudomonas phages

Indexed keywords

ARTICLE; BIOLOGICAL THERAPY; GROWTH, DEVELOPMENT AND AGING; INTERSPECIES PHAGE MIGRATIONS; ISOLATION AND PURIFICATION; METHODOLOGY; PHAGE THERAPY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS AERUGINOSA BACTERIOPHAGES; PSEUDOMONAS INFECTION; PSEUDOMONAS PHAGE; SPECIES OF TRANSPOSABLE PSEUDOMONAS PHAGES; VIROLOGY;

INTERSPECIES PHAGE MIGRATIONS; PHAGE THERAPY; PSEUDOMONAS AERUGINOSA BACTERIOPHAGES; SPECIES OF TRANSPOSABLE PSEUDOMONAS PHAGES;

BIOLOGICAL THERAPY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PSEUDOMONAS PHAGES;

EID: 84891113864     PISSN: 00653527     EISSN: 15578399     Source Type: Book Series    
DOI: 10.1016/B978-0-12-800098-4.00005-2     Document Type: Chapter

References (182)

1. Ahiwale S., Tamboli N., Thorat K., Kulkarni R., Ackermann H., Kapadnis B. In vitro management of hospital Pseudomonas aeruginosa biofilm using indigenous T7-like lytic phage. Current Microbiology 2011, 62:335.
2. Akhverdian V.Z., Khrenova E.A., Lobanov A.O., Krylov V.N. Role of divergence in evolution of group B3 Pseudomonas aeruginosa transposable phage. Genetika 1998, 34:846.
3. Akhverdian V.Z., Khrenova E.A., Reulets M.A., Gerasimova T.V., Krylov V.N. The properties of transposable phages of Pseudomonas aeruginosa belonging to two groups distinguished by DNA-DNA homology. Genetika 1985, 21:735.
4. Akhverdian V.Z., Lobanov A.O., Khrenova E.A., Krylov V.N. Recombinational origin of natural transposable phages of related species belonging to group B3, active in Pseudomonas aeruginosa species. Genetika 1998, 34:697.
5. Akhverdian V.Z., Reulets M.A., Plotnikova T.G., Krylov V.N. Effective, plasmid RP4-dependent replication-transposition of DNA of the transposable phage D3112 of Pseudomonas aeruginosa in a heterologous Escherichia coli system. Genetika 1986, 22:2048.
6. Antonov V.A., Altukhova V.V., Savchenko S.S., Tkachenko G.A., Zamaraev V.S., Zhukova S.I., et al. Molecular genetic analysis of Pseudomonas aeruginosa strains isolated from environment and patients in health care facilities. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii 2010, 2:8.
7. Armstrong D., Bell S., Robinson M., Bye P., Rose B., Harbour C., et al. Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics. Journal of Clinical Microbiology 2003, 41:2266.
8. Aslanov B.I., Iafaev R.Kh., Zueva L.P. Mode of the rational use of Pseudomonas aeruginosa bacteriophages in therapeutic and epidemic control practice. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii 2003, 5:72.
9. Bae H.W., Chung I.Y., Sim N., Cho Y.H. Complete genome sequence of Pseudomonas aeruginosa siphophage MP1412. Journal of Virology 2012, 86(17):9537.
10. Barbier F., Wolff M. Multi-drug resistant Pseudomonas aeruginosa: Towards a therapeutic dead endα. Medical Science (Paris) 2010, 26:960.
11. Bidnenko E.M., Akhverdian V.Z., Khrenova E.A., Ianenko A.S., Krylov V.N. Genetic control of morphogenesis of Pseudomonas aeruginosa transposable phage D3112. Genetika 1989, 25:2126.
12. Bille E., Zahar J.R., Perrin A., Morelle S., Kriz P., Jolley K.A., et al. A chromosomally integrated bacteriophage in invasive meningococci. Journal of Experimental Medicine 2005, 201:1905.
13. Blahová J., Králiková K., Krcméry V., Mikovicová A., Bartoníková N. Two high-frequency-transduction phage isolates from lysogenic strains of Pseudomonas aeruginosa transducing antibiotic resistance. Acta Virologica 1998, 42:175.
14. Bodey G.P., Bolivar R., Feinstein V., Jadeja L. Infections caused by Pseudomonas aeruginosa. Reviews of Infectious Diseases 1983, 5:279.
15. Bogush V.G., Plotnikova T.G., Kirsanov N.B., Rebentish B.A., Permogorov V.I., Krylov V.N. Bacteriophages of Pseudomonas aeruginosa with DNA similar in structure to that of phage Mu1. III. Isolation and analysis of hybrid phages D3112 and B39: Localization of the immunity region and some genetic factors. Genetika 1981, 17:967.
16. Bondy-Denomy J., Pawluk A., Maxwell K.L., Davidson A.R. Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system. Nature 2013, 7432:429.
17. Bourkal'tseva M.V., Krylov V.N., Pleteneva E.A., Shaburova O.V., Krylov S.V., Volkart G., et al. Phenogenetic characterization of a group of giant fKZ-like bacteriophages of Pseudomonas aeruginosa. Russian Journal of Genetics 2002, 38:1242.
18. Braid M.D., Silhavy J.L., Kitts C.L., Cano R.J., Howe M.M. Complete genomic sequence of bacteriophage B3, a Mu-like phage of Pseudomonas aeruginosa. Journal of Bacteriology 2004, 186:6560.
19. Briers Y., Lavigne R., Plessers P., Hertveldt K., Hanssens I., Engelborghs Y., et al. Stability analysis of the bacteriophage phiKMV lysin gp36C and its putative role during infection. Cellular and Molecular Life Sciences 2006, 63:1899.
20. Brockhurst M.A., Buckling A., Rainey P.B. The effect of a bacteriophage on diversification of the opportunistic bacterial pathogen, Pseudomonas aeruginosa. Proceedings. Biological Sciences/The Royal Society 2005, 272:1385.
21. Brüssow H., Canchaya C., Hardt W.D. Phages and the evolution of bacterial pathogens: From genomic rearrangements to lysogenic conversion. Microbiology and Molecular Biology Reviews 2004, 68:560.
22. Budak A., Paluchowska P., Włodarczyk D., Nowak P., Wegrzyn M., Mudyna W. The genetic description of Acinetobacter baumannii and Pseudomonas aeruginosa strains isolated from patients with hospital acquired pneumonia hospitalized in intensive care unit. Medycyna Doswiadczalna I Mikrobiologia 2010, 62:67.
23. Budzik J.M., Rosche W.A., Rietsch A., O'Toole G.A. Isolation and characterization of a generalized transducing phage for Pseudomonas aeruginosa strains PAO1 and PA14. Journal of Bacteriology 2004, 186:3270.
24. Burkal'tseva M.V., Pleteneva E.A., Shaburova O.V., Kadykov V.A., Krylov V.N. Genome conservatism of phiKMV-like bacteriophages (T7 supergroup) active against Pseudomonas aeruginosa. Genetika 2006, 42:33.
25. Byrne M., Kropinski A.M. The genome of the Pseudomonas aeruginosa generalized transducing bacteriophage F116. Gene 2005, 14:187.
26. Cady K.C., White A.S., Hammond J.H., Abendroth M.D., Karthikeyan R.S., Prajna L., et al. Prevalence, conservation and functional analysis of Yersinia and Escherichia CRISPR regions in clinical Pseudomonas aeruginosa Isolates. Microbiology 2010, 157:430.
27. Cao J., Sun Y., Berglindh T., Mellgård B., Li Z., Mårdh B., et al. Helicobacter pylori-antigen-binding fragments expressed on the filamentous M13 phage prevent bacterial growth. Biochimica et Biophysica Acta 2000, 1474:107.
28. Centers for Disease Control. (1997). Guidelines for prevention of nosocomial pneumonia. MMWR Morb Mortal Wkly Rep 46, 1.
29. Ceyssens P.J., Brabban A., Rogge L., Lewis M.S., Pickard D., Goulding D., et al. Molecular and physiological analysis of three Pseudomonas aeruginosa phages belonging to the "N4-like viruses". Virology 2010, 405(1):26.
30. Ceyssens P.J., Hertveldt K., Ackermann H.-W., Noben J.P., Demeke M., Volckaert G., et al. The intron-containing genome of the lytic Pseudomonas phage LUZ24 resembles the temperate phage PaP3. Virology 2008, 377:233.
31. Ceyssens P.J., Lavigne R. Bacteriophages of Pseudomonas. Future Microbiology 2010, 5(7):1041.
32. Ceyssens P.J., Miroshnikov K., Mattheus W., Krylov V., Robben J., Noben J.P., et al. Comparative analysis of the widespread and conserved PB1-like viruses infecting Pseudomonas aeruginosa. Environmental Microbiology 2009, 11:2874.
33. Ceyssens P.J., Noben J.P., Ackermann H.W., Verhaegen J., De Vos D., Pirnay J.P., et al. Survey of Pseudomonas aeruginosa and its phages: De novo peptide sequencing as a novel tool to assess the diversity of worldwide collected viruses. Environmental Microbiology 2009, 11:1303.
34. Chattoraj S.S., Murthy R., Ganesan S., Goldberg J.B., Zhao Y., Hershenson M.B., et al. Pseudomonas aeruginosa alginate promotes Burkholderia cenocepacia persistence in cystic fibrosis transmembrane conductance regulator knockout mice. Infection and Immunity 2010, 78:984.
35. Coenye T., Spilker T., Van Schoor A., LiPuma J.J., Vandamme P. Recovery of Burkholderia cenocepacia strain PHDC from cystic fibrosis patients in Europe. Thorax 2004, 59:952.
36. Cornelissen A., Hardies S.C., Shaburova O.V., Krylov V.N., Mattheus W., Kropinski A.M., et al. Complete genome sequence of the giant virus OBP and comparative genome analysis of the diverse ΦKZ-related phages. Journal of Virology 2012, 86(3):1844.
37. Courchesne N.M., Parisien A., Lan C.Q. Production and application of bacteriophage and bacteriophage-encoded lysins. Recent Patents on Biotechnology 2009, 3:37.
38. Darzins A., Chakrabarty A. Cloning of genes controlling alginate biosynthesis from a mucoid cystic fibrosis isolate of Pseudomonas aeruginosa. Journal of Bacteriology 1984, 159:9.
39. Desplats C., Krisch H.M. The diversity and evolution of the T4-type bacteriophages. Research in Microbiology 2003, 154:259.
40. Dzhusupova A.B., Plotnikova T.G., Krylov V.N. Detection of transduction by virulent bacteriophage phiKZ of Pseudomonas aeruginosa chromosomal markers in the presence of plasmid RMS148. Genetika 1982, 18:1799.
41. Dzuliashvili M., Gabitashvili K., Golidjashvili A., Hoyle N., Gachechiladze K. Study of therapeutic potential of the experimental pseudomonas bacteriophage preparation. Georgian Medical News 2007, 147:81.
42. El Zoeiby A., Sanschagrin F., Darveau A., Brisson J.-R., Levesque R.C. Identification of novel inhibitors of Pseudomonas aeruginosa Mur C enzyme derived from phage-displayed peptide libraries. Journal of Antimicrobial Chemotherapy 2003, 51:531.
43. Emerson J., McNamara S., Buccat A.M., Worrell K., Burns J.L. Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008. Pediatric Pulmonology 2010, 45:363.
44. Finnan S., Morrissey J.P., O'Gara F., Boyd E.F. Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment. Journal of Clinical Microbiology 2004, 42:5783.
45. Fischetti V.A. Bacteriophage endolysins: A novel anti-infective to control Gram-positive pathogens. International Journal of Medical Microbiology 2010, 300:357.
46. Freǐzon E.V., Kopylova Iu.I., Cheremukhina L.V., Krylov V.N. The effect of the IncP-2-group plasmid on the growth of Pseudomonas aeruginosa bacteriophages. Genetika 1989, 25:1168.
47. Gabriélian N.I., Gorskaia E.M., Spirina T.S., Darbeeva O.S., Maǐskaia L.M. Sensitivity of nosocomial microflora circulating in a transplantation clinic to medicinal bacteriophages. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii 2004, 6:6.
48. Garbe J., Bunk B., Rohde M., Schobert M. Sequencing and characterization of Pseudomonas aeruginosa phage JG004. BMC Microbiology 2011, 11:102.
49. Garbe J., Wesche A., Bunk B., Kazmierczak M., Selezska K., Rohde C., et al. Characterization of JG024, a Pseudomonas aeruginosa PB1-like broad host ranges phage under simulated infection condition. BMC Microbiology 2010, 10:301.
50. Gerasimov V.A., Eremenko E.N., Khrenova E.A., Gorbunova S.A., Krylov V.N. Stimulation of the lysogenization of Pseudomonas aeruginosa cells by phage transposon B39 induced by plasmid Rms163. Genetika 1984, 20:1080.
51. Gerasimov V.A., Ianenko A.S., Akhverdian V.Z., Krylov V.N. Interaction between Pseudomonas aeruginosa phages-transposons: Genetic analysis of the trait of inhibition by prophage D3112 of phage B39 development. Genetika 1996, 32:1068.
52. Gilleland H.E., Gilleland L.B., Fowler M.R. Vaccine efficacies of elastase, exotoxin A, and outer-membrane protein F in preventing chronic pulmonary infection by Pseudomonas aeruginosa in a rat model. Journal of Medical Microbiology 1993, 38:79.
53. Glonti T., Chanishvili N., Taylor P.W. Bacteriophage-derived enzyme that depolymerizes the alginic acid capsule associated with cystic fibrosis isolates of Pseudomonas aeruginosa. Journal of Applied Microbiology 2010, 108:695.
54. Golshahi L., Lynch K.H., Dennis J.J., Finlay W.H. In vitro lung delivery of bacteriophages KS4-M and ΦKZ using dry powder inhalers for treatment of Burkholderia cepacia complex and Pseudomonas aeruginosa infections in cystic fibrosis. Journal of Applied Microbiology 2011, 110:106.
55. Gorbunova S.A., Ianenko A.S., Akhverdian V.Z., Reulets M.A., Krylov V.N. Expression of Pseudomonas aeruginosa transposable phages in Pseudomonas putida cells. I. The establishment of a lysogenic state and the effectiveness of lytic development. Genetika 1985, 21:1455.
56. Goudie A.D., Lynch K.H., Seed K.D., Stothard P., Shrivastava S., Wishart D.S., et al. Genomic sequence and activity of KS10, a transposable phage of the Burkholderia cepacia complex. BMC Genomics 2008, 9:615.
57. Hagens S., Bläsi U. Genetically modified filamentous phage as bactericidal agents: A pilot study. Letters in Applied Microbiology 2003, 37:318.
58. Hagens S., Habel A., von Ahsen U., von Gabain A., Bläsi U. Therapy of experimental pseudomonas infections with a nonreplicating genetically modified phage. Antimicrobial Agents and Chemotherapy 2004, 48:3817.
59. Harrison F. Microbial ecology of cystic fibrosis lung. Microbiology 2007, 153:917.
60. Hens D.K., Chatterjee N.C., Kumar R. New temperate DNA phage BcP15 acts as a drug resistance vector. Archives of Virology 2006, 151:1345.
61. Heo Y.J., Chung I.Y., Choi K.B., Lau G.W., Cho Y.H. Genome sequence comparison and superinfection between two related Pseudomonas aeruginosa phages, D3112 and MP22. Microbiology 2007, 153:2885.
62. Hertveldt K., Lavigne R., Pleteneva E., Sernova N., Kurochkina L., Korchevskii R., et al. Genome comparison of Pseudomonas aeruginosa large phages. Journal of Molecular Biology 2005, 354:536.
63. Holloway B.W., Egan J.B., Monk M. Lysogeny in Pseudomonas aeruginosa. Australian Journal of Experimental Biology & Medical Science 1960, 38:321.
64. Ianenko A.S., Bekkarevich A.O., Gerasimov V.A., Krylov V.N. Genetic map of the transposable phage D3112 of Pseudomonas aeruginosa. Genetika 1988, 24:2120.
65. INTRALYTIX: http://www.intralytix.com/.
66. Ito S., Kageyama M. Relationship between pyocins and bacteriophage in Pseudomonas aeruginosa. The Journal of General and Applied Microbiology 1970, 16:231.
67. Jain S., Ohman D.E. Role of an alginate lyase for alginate transport in mucoid Pseudomonas aeruginosa. Infection and Immunity 2005, 73:6429.
68. Jarrell K.F., Kropinski A.M. Isolation and characterization of a bacteriophage specific for the lipopolysaccharide of rough derivatives of Pseudomonas aeruginosa strain PAO. Journal of Virology 1981, 38:529.
69. Johansen H., Gøtzsche P.C. Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis. Cochrane Database of Systematic Reviews 2008, 4:CD001399.
70. Kageyama M., Kobayashi M., Sano Y., Masaki H. Construction and characterization of pyocin-colicin chimeric proteins. Journal of Bacteriology 1996, 178:103.
71. Kageyama M., Shinomiya T., Aihara Y., Kobayashi M. Characterization of a bacteriophage related to R-type pyocins. Journal of Virology 1979, 32:951.
72. Kamei A., Coutinho-Sledge Y.S., Goldberg J.B., Priebe G.P., Pier G.B. Mucosal vaccination with a multivalent, live-attenuated vaccine induces multi-factorial immunity against Pseudomonas aeruginosa acute lung infection. Infection and Immunity 2011, 79:1289.
73. Kaplan A.M., Akhverdian V.Z., Krylov V.N. Integration of phage Mu into the RP4::D3112-plasmid in Escherichia coli cells. Genetika 1989, 25:1384.
74. Kaplan A.M., Akhverdian V.Z., Reulets M.A., Krylov V.N. Compatibility of transposable phages of Escherichia coli and Pseudomonas aeruginosa. I. Co-development of phages Mu and D3112 and integration of phage D3112 into RP4::Mu plasmid in Pseudomonas aeruginosa cells. Genetika 1988, 24:634.
75. Karumidze N., Thomas J.A., Kvatadze N., Goderdzishvili M., Hakala K.W., Weintraub S.T., et al. Characterization of lytic Pseudomonas aeruginosa bacteriophages via biological properties and genomic sequences. Applied Microbiology and Biotechnology 2012, 94(6):1609.
76. Kenna D.T., Barcus V.A., Langley R.J., Vandamme P., Govan J.R. Lack of correlation between O-serotype, bacteriophage susceptibility and genomovar status in the Burkholderia cepacia complex. FEMS Immunology and Medical Microbiology 2003, 35:87.
77. Kim M.S., Cha K.E., Myung H. Complete genome of Pseudomonas aeruginosa phage PA26. Journal of Virology 2012, 86(18):10244.
78. Kim S., Rahman M., Seol S.Y., Yoon S.S., Kim J. Pseudomonas aeruginosa bacteriophage PA1Ø requires type IV pili for infection and shows broad bactericidal and biofilm removal activities. Applied and Environmental Microbiology 2012, 78(17):63805.
79. Kopylova Iu.I., Gorbunova S.A., Krylov V.N. Interaction of heterologous bacteriophages: Growth suppression of temperate PP56 phage of Pseudomonas putida by the transposable phage D3112 of Pseudomonas aeruginosa. Genetika 1988, 24:803.
80. Kozlov D.G., Cheperigin S.E., Chestkov A.V., Krylov V.N., Tsygankov Iu.D. Cloning and expression of bacteriophage FMV lysozyme gene in cells of yeasts Saccharomyces cerevisiae and Pichia pastoris. Genetika 2010, 46:340.
81. Kropinski A.M. Sequence of the genome of the temperate, serotype-converting, Pseudomonas aeruginosa bacteriophage D3. Journal of Bacteriology 2000, 182:6066.
82. Kropinski A.M. Phage therapy-Everything old is new again. The Canadian Journal of Infectious Diseases & Medical Microbiology 2006, 17:297.
83. Krumsiek J., Arnold R., Rattei T. Gepard: A rapid and sensitive tool for creating dotplots on genome scale. Bioinformatics 2007, 23:1026.
84. Krylov V.N. Phagotherapy in terms of bacteriophage genetics: Hopes, perspectives, safety, limitations. Genetika 2001, 37:869.
85. Krylov V.N., Akhverdian V.Z., Bogush V.G., Khrenova E.A., Reulets M.A. Modular structure of the genes of phages-transposons of Pseudomonas aeruginosa. Genetika 1985, 21:724.
86. Krylov V.N., Akhverdian V.Z., Khrenova E.A., Cheremukhina L.V., Tiaglov B.V. 2 types of molecular structure (composition) of a genome in one species of transposable bacteriophages of Pseudomonas aeruginosa. Genetika 1986, 22:2637.
87. Krylov V.N., Bogush V.G., Ianenko A.S., Kirsanov N.B. Bacteriophages of Pseudomonas aeruginosa with DNA similar in structure to that of phage Mu1. II. Evidence of relatedness of bacteriophages D3112, V3 and V39: Analysis of DNA digestion with restrictional endonucleases, isolation of recombinant of phages D3112 and V3. Genetika 1980, 16:975.
88. Krylov V.N., Bogush V.G., Shapiro J. Bacteriophages of Pseudomonas aeruginosa with DNA similar in structure to that of phage Mu1. I. General description, localization of sites sensitive to endonucleases in DNA, and structure of homoduplexes of phage D3112. Genetika 1980, 16:824.
89. Krylov V.N., Burkal'tseva M.V., Sykilinda N.N., Pleteneva E.A., Shaburova O.V., Kadykov V.A., et al. Comparison of genomes of new gigantic Pseudomonas aeruginosa phages from native populations from different regions. Russian Journal of Genetics 2004, 40:363.
90. Krylov V.N., Dela Cruz D.M., Hertveldt K., Ackermann H.-W. "phiKZ-like viruses", a proposed new genus of myovirus bacteriophages. Archives of Virology 2007, 152:1955.
91. Krylov V.N., Eremenko E.N., Bogush V.G., Kirsanov N.B. Interaction of Pseudomonas aeruginosa plasmids and mu-like phages: The suppression of the early stages of cell infection by phage D3112 in the presence of plasmid RPL11. Genetika 1982, 18:743.
92. Krylov V.N., Ianenko A.S., Cheremukhina L.V. Differences in the allele state of genes controlling the specificity of adsorption in transposable phages of Pseudomonas aeruginosa. Genetika 1986, 22:1093.
93. Krylov V., Merlin C., Toussaint A. Introduction of Pseudomonas aeruginosa mutator phage D3112 in Alcaligenes eutrophus strain CH34. Researches in Microbiology 1995, 146:245.
94. Krylov V.N., Miroshnikov K.A., Krylov S.V., Veǐko V.P., Pleteneva E.A., Shaburova O.V., et al. Interspecific migration and evolution of bacteriophages of the genus phiKZ: The purpose and criteria of the search for new phiKZ-like bacteriophages. Genetika 2010, 46:159.
95. Krylov V.N., Mit'kina L.N., Pleteneva E.A., Aleshin V.V. Cryptic transposable phages of Pseudomonas aeruginosa. Genetika 1995, 31:1507.
96. Krylov S.V., Pleteneva E.A., Bourkaltseva M.V., Shaburova O.V., Miroshnikov K.A., Lavigne R., et al. Genome instability of Pseudomonas aeruginosa phages of the EL species: Examination of virulent mutants. Russian Journal of Genetics 2011, 47:162.
97. Krylov V.N., Pleteneva E.A., Lavigne R., Hertveldt K., Volkaert G., Sernova N.V., et al. Comparison of the genome for phylogenetically related bacteriophages phiKZ and EL of Pseudomonas aeruginosa: Evolutionary aspects and minimal genome size. Genetika 2005, 41:455.
98. Krylov V.N., Plotnikova T.G., Kulakov L.A., Fedorova T.V., Eremenko E.N. Integration of the genome of the Mu-like Pseudomonas aeruginosa bacteriophage D3112 into plasmid RP4 and its hybrid plasmid transfer into Pseudomonas putida and Escherichia coli C600 bacteria. Genetika 1982, 18:5.
99. Krylov V.N., Smirnova T.A., Minenkova I.B., Plotnikova T.G., Zhazikov I.Z., Khrenova E.A. Pseudomonas bacteriophage phiKZ contains an inner body in its capsid. Canadian Journal of Microbiology 1984, 30:758.
100. Krylov V.N., Tolmachova T.O., Akhverdian V.Z. DNA homology in species of bacteriophages active on Pseudomonas aeruginosa. Archives of Virology 1993, 131:141.
101. Krylov V.N., Zhazykov I.Zh. Pseudomonas bacteriophage phiKZ-Possible model for studying the genetic control of morphogenesis. Genetika 1978, 14:678.
102. Kulakov L.A., Gorelyshev A.G., Kulba A.V., Krylov V.N. Investigation of Pseudomonas putida PpG1 resistance to different bacteriophages. Genetika 1981, 17:1737.
103. Kulakov L.A., Mazepa V.N., Boronin A.M. Effect of plasmids from various incompatibility groups on the development of bacteriophages specific to Pseudomonas aeruginosa and Pseudomonas putida. Mikrobiologiia 1984, 53:471.
104. Kutter E., De Vos D., Gvasalia G., Alavidze Z., Gogokhia L., Kuhl S., et al. Phage therapy in clinical practice: Treatment of human infections. Current Pharmaceutical Biotechnology 2010, 11:69.
105. Kuzio J., Kropinski A.M. O-antigen conversion in Pseudomonas aeruginosa PAO1 by bacteriophage D3. Journal of Bacteriology 1983, 155:203.
106. Lelong E., Marchetti A., Simon M., Burns J.L., van Delden C., Köhler T., et al. Evolution of Pseudomonas aeruginosa virulence in infected patients revealed in a Dictyostelium discoideum host model. Clinical Microbiology and Infection 2011, 17(9):1415.
107. Letkiewicz S., Miedzybrodzki R., Kłak M., Jończyk E., Weber-Dabrowska B., Górski A. The perspectives of the application of phage therapy in chronic bacterial prostatitis. FEMS Immunology and Medical Microbiology 2010, 60(2):99.
108. Lindberg R.B., Latta R.L. Phage typing of Pseudomonas aeruginosa: Clinical and epidemiologic considerations. Journal of Infectious Diseases 1974, 130:S33.
109. Lynch K.H., Seed K.D., Stothard P., Dennis J.J. Inactivation of Burkholderia cepacia complex phage KS9 gp41 identifies the phage repressor and generates lytic virions. Journal of Virology 2010, 84(3):1276.
110. Lynch K.H., Stothard P., Dennis J.J. Genomic analysis and relatedness of P2-like phages of the Burkholderia cepacia complex. BMC Genomics 2010, 1:599.
111. MacGeorge J., Korolik V., Morgan A.F., Asche V., Holloway B.W. Transfer of a chromosomal locus responsible for mucoid colony morphology in Pseudomonas aeruginosa isolated from cystic fibrosis patients to P. aeruginosa PAO. Journal of Medical Microbiology 1986, 21:331.
112. Martin D.W., Schurr M.J., Mudd M.H., Govan J.R., Holloway B.W., Deretic V. Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proceedings of the National Academy of Sciences of the United States of America 1993, 90:8377.
113. Mayer K.H., Hopkins J.D., Gilleece E.S., Chao L., O'Brien T.F. Molecular evolution, species distribution, and clinical consequences of an endemic aminoglycoside resistance plasmid. Antimicrobial Agents and Chemotherapy 1986, 29:628.
114. McCallum S.J., Gallagher M.J., Corkill J.E., Hart C.A., Ledson M.J., Walshaw M.J. Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives. Thorax 2002, 57:559.
115. Merabishvili M., Verhelst R., Glonti T., Chanishvili N., Krylov V., Cuvelier C., et al. Digitized fluorescent RFLP analysis (fRFLP) as a universal method for comparing genomes of culturable dsDNA viruses: Application to bacteriophages. Research in Microbiology 2007, 158:572.
116. Mesyanzhinov V.V., Robben J., Grymonprez B., Kostyuchenko V.A., Bourkaltseva M.V., Sykilinda N.N., et al. The genome of bacteriophage phiKZ of Pseudomonas aeruginosa. Journal of Molecular Biology 2002, 317:1.
117. Miedzybrodzki R., Borysowski J., Weber-Dabrowska B., Fortuna W., Letkiewicz S., Szufnarowski K., et al. Clinical aspects of phage therapy. Advances in Virus Research 2012, 83:73.
118. Miller R.V., Pemberton J.M., Richards K.E. F116, D3 and G101: Temperate bacteriophages of Pseudomonas aeruginosa. Virology 1974, 59:566.
119. Mit'kina L.N., Krylov V.N. Natural interspecific hybrids of transposable phages of Pseudomonas aeruginosa. Genetika 1999, 35:1182.
120. Mit'kina L.N., Krylov V.N. Properties of natural interspecific hybrids of transposable phages of Pseudomonas aeruginosa: Specific characteristics of phage PL24 transposition. Genetika 2000, 36:1330.
121. Mohan K., Fothergill J.L., Storrar J., Ledson M.J., Winstanley C., Walshaw M.J. Transmission of Pseudomonas aeruginosa epidemic strain from a patient with cystic fibrosis to a pet cat. Thorax 2008, 63(9):839.
122. Nakayama K., Kanaya S., Ohnishi M., Terawaki Y., Hayashi T. The complete nucleotide sequence of, a cytotoxin-converting phage of Pseudomonas aeruginosa: Implications for phage evolution and horizontal gene transfer via bacteriophages. Molecular Microbiology 1999, 31:399.
123. Newton G.J., Daniels C., Burrows L.L., Kropinski A.M., Clarke A.J., Lam J.S. Three-component-mediated serotype conversion in Pseudomonas aeruginosa by bacteriophage D3. Lysogenization with phage D3 alters the structure of surface lipopolysaccharides. Molecular Microbiology 2001, 39:1237.
124. Novikova I.S., Glatman L.I., Terekhov A.A., Kravets A.N., Moroz A.F. Possible dependence of the results of phage typing Ps. aeruginosa strains on the presence of R plasmids. Antibiotiki 1983, 28:278.
125. Nzula S., Vandamme P., Govan J.R. Sensitivity of the Burkholderia cepacia complex and Pseudomonas aeruginosa to transducing bacteriophages. FEMS Immunology and Medical Microbiology 2000, 28:307.
126. Ojeniyi B., Birch-Andersen A., Mansa B., Rosdahl V.T., Hoiby N. Morphology of phages Pseudomonas aeruginosa from the sputum of cystic fibrosis patient and from phage typing set. An electron microscopy study. Acta Pathologica, Microbiologica et Immunologica Scandinavica 1991, 99:925.
127. Oliver A., Mena A. Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance. Clinical Microbiology and Infection 2010, 16:798.
128. Panagea S., Winstanley C., Walshaw M.J., Ledson M.J., Hart C.A. Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces. Journal of Hospital Infection 2005, 59(2):102.
129. Parisien A., Allain B., Zhang J., Mandeville R., Lan C. Novel alternatives to antibiotics: Bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides. Journal of Applied Microbiology 2008, 104:1.
130. Perepanova T.S., Darbeeva O.S., Kotliarova G.A., Kondrat'eva E.M., Maǐskaia L.M., Malysheva V.F., et al. The efficacy of bacteriophage preparations in treating inflammatory urologic diseases. Urologiia i Nefrologia 1995, 5:14.
131. Piekarowicz A., Kłyz A., Majchrzak M., Adamczyk-Popławska M., Maugel T.K., Stein D.C. Characterization of the dsDNA prophage sequences in the genome of Neisseria gonorrhoeae and visualization of productive bacteriophage. BMC Microbiology 2007, 7:66.
132. Pleteneva E.A., Bourkaltseva M.V., Shaburova O.V., Krylov S.V., Pechnikova E.V., Sokolova O.S., et al. TL, the new bacteriophage of Pseudomonas aeruginosa and its application for the search of halo-producing bacteriophages. Russian Journal of Genetics 2011, 47:1.
133. Pleteneva E.A., Krylov S.V., Shaburova O.V., Burkal'tseva M.V., Miroshnikov K.A., Krylov V.N. Pseudolysogeny of Pseudomonas aeruginosa bacteria infected with phiKZ-like bacteriophages. Genetika 2010, 46:26.
134. Pleteneva E.A., Shaburova O.V., Krylov V.N. A formal scheme of adsorptional receptors in Pseudomonas aeruginosa and possibilities for Its practical implementation. Russian Journal of Genetics 2009, 45:35.
135. Pleteneva E.A., Shaburova O.V., Sykilinda N.N., Miroshnikov K.A., Krylov S.V., Mesianzhinov V.V., et al. Study of the diversity in a group of phages of Pseudomonas aeruginosa species PB1 (Myoviridae) and their behavior in adsorbtion-resistant bacterial mutants. Genetika 2008, 44:185.
136. Plotnikova T.G., Akhverdian V.Z., Reulets M.A., Gorbunova S.A., Krylov V.N. Multiplicity of the integration sites of Mu-like bacteriophages into Pseudomonas aeruginosa chromosome and plasmids. Genetika 1983, 19:1604.
137. Plotnikova T.G., Dzhusupova A.B., Khrenova E.A., Krylov V.N. Genetic and phylogenetic study of the ts-mutant group of Pseudomonas aeruginosa PA01 phage phi KZ. Genetika 1982, 18:1793.
138. Plotnikova T.G., Ianenko A.S., Kirsanov N.B., Krylov V.N. Transposition of the phage D3112 genome in Escherichia coli cells. Genetika 1983, 19:1611.
139. Plotnikova T.G., Kulakov L.A., Eremenko E.N., Fedorova T.V., Krylov V.N. Expression of the genome of Mu-like phage D3112 specific for Pseudomonas aeruginosa in Escherichia coli and Pseudomonas putida cells. Genetika 1982, 18:1075.
140. Professor Demchick's Patent Services: http://www.professorpatents.com/.
141. Rakhuba D.V., Kolomiets E.I., Dey E.S., Novik G.I. Bacteriophage receptors, mechanisms of phage adsorption and penetration into host cell. Polish Journal of Microbiology 2010, 59(3):145.
142. Rakonjac J., Bennett N.J., Spagnuolo J., Gagic D., Russel M. Filamentous bacteriophage: Biology, phage display and nanotechnology applications. Current Issues in Molecular Biology 2011, 13(2):51.
143. Rao V.B., Black L.W. Structure and assembly of bacteriophage T4 head. Virology Journal 2010, 3:356.
144. Rehmat S., Shapiro J.A. Insertion and replication of the Pseudomonas aeruginosa mutator phage D3112. Molecular & General Genetics 1983, 192:416.
145. Ren Z., Black L.W. Phage T4 SOC and HOC display of biologically active, full-length proteins on the viral capsid. Gene 1998, 215:439.
146. Rice S.A., Tan C.H., Mikkelsen P.J., Kung V., Woo J., Tay M., et al. The biofilm life cycle and virulence of Pseudomonas aeruginosa are dependent on a filamentous prophage. ISME Journal 2009, 3:271.
147. Riou M., Carbonnelle S., Avrain L., Mesaros N., Pirnay J.P., Bilocq F., et al. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients and receiving antipseudomonal therapy. International Journal of Antimicrobial Agents 2010, 36:513.
148. Rogers G.B., Carroll M.P., Serisier D.J., Hockey P.M., Kehagia V., Jones G.R., et al. Bacterial activity in cystic fibrosis lung infections. Respiratory Research 2005, 6:49.
149. Rolain J.M., Fancello L., Desnues C., Raoult D. Bacteriophages as vehicles of the resistome in cystic fibrosis. Journal of Antimicrobial Chemotherapy 2011, 66(11):2444.
150. Roncero C., Darzins A., Casadaban M.J. Pseudomonas aeruginosa transposable bacteriophages D3112 and B3 require pili and surface growth for adsorption. Journal of Bacteriology 1990, 172:1899.
151. Ronning C.M., Losadam L., Brinkac L., Inman J., Ulrich R.L., Schell M., et al. Genetic and phenotypic diversity in Burkholderia: Contributions by prophage and phage-like elements. BMC Microbiology 2010, 10:202.
152. Sathaliyawala T., Islam M.Z., Li Q., Fokine A., Rossmann M.G., Rao V.B. Functional analysis of the highly antigenic outer capsid protein, Hoc, a virus decoration protein from T4-like bacteriophages. Molecular Microbiology 2010, 77:444.
153. Saussereau E., Debarbieux L. Bacteriophages in the experimental treatment of Pseudomonas aeruginosa infections in mice. Advances in Virus Research 2012, 83:123.
154. Shabalova I.A., Kapranov N.I., Krylov V.N., Sharibjanova T.O., Akhverdian V.Z. Pseudomonas aeruginosa bacteriophage in treatment of P. aeruginosa infection in cystic fibrosis patients 1995, International Cystic Fibrosis Association, Zurich, Switzerland.
155. Shaburova O.V., Hertveldt K., de la Crus D.M., Krylov S.V., Pleteneva E.A., Burkaltseva M.V., et al. Comparison of new giant bacteriophages OBP and Lu11 of soil pseudomonads with bacteriophages of phiKZ-supergroup of Pseudomonas aeruginosa. Genetika 2006, 42:1065.
156. Shaburova O.V., Krylov S.V., Veǐko V.P., Pleteneva E.A., Burkal'tseva M.V., Miroshnikov K.A., et al. Search for destruction factors of bacterial biofilms: Comparison of phage properties in a group of Pseudomonas putida bacteriophages and specificity of their halo-formation products. Genetika 2009, 45:185.
157. Shaburova O.V., Pleteneva E.A., Hertveldt K., Krylov V.N. Comparison of DNA sizes in a group of giant Pseudomonas aeruginosa phages by the PFGE method. Russian Journal of Genetics 2008, 44:620.
158. Sharibzhanova T.O., Akhverdyan V.Z., Krylov V.N. A comparative study of DNA homology and morphology of Pseudomonas aeruginosa bacteriophages to reveal phylogenetic relationship and for express-classification. Genetika 1992, 28:24.
159. Shen K., Sayeed S., Antalis P., Gladitz J., Ahmed A., Dice B., et al. Extensive genomic plasticity in Pseudomonas aeruginosa revealed by identification and distribution studies of novel genes among clinical isolates. Infection and Immunity 2006, 74:5272.
160. Shinagawa N., Hasegawa M., Hirata K., Furuhata T., Mizukuchi T., Osanai H., et al. Bacteria isolated from surgical infections and their susceptibilities to antimicrobial agents-Special references to bacteria isolated between April 2008 and March 2009. Japanese Journal of Antibiotics 2010, 63:105.
161. Slopek S., Weber-Dabrowska B., Dabrowski M., Kucharewicz-Krukowska A. Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986. Archivum Immunologiae et Therapiae Experimentalis 1987, 35:569.
162. Stone R. Bacteriophage therapy: Stalin's forgotten cure. Science 2002, 298:728.
163. Summer E.J., Gonzalez C.F., Carlisle T., Mebane L.M., Cass A.M., Savva C.G., et al. Burkholderia cenocepacia phage BcepMu and a family of Mu-like phages encoding potential pathogenesis factors. Journal of Molecular Biology 2004, 340:49.
164. Summers W.C. Bacteriophage therapy. Annual Review of Microbiology 2001, 55:437.
165. Phage Mu: Cold Spring Harbor 1987, Cold Spring Harbor Laboratory, New York. N. Symonds, A. Toussaint, P. van de Putte, M.M. Howe (Eds.).
166. Taylor A.L. Bacteriophage-induced mutations in E. coli. Proceedings of the National Academy of Sciences of the United States of America 1963, 50:1043.
167. Tejedor C., Foulds J., Zasloff M. Bacteriophages in sputum of patients with bronchopulmonary pseudomonas infections. Infection and Immunity 1982, 36:440.
168. Thomas J.A., Rolando M.R., Carroll C.A., Shen P.S., Belnap D.M., Weintraub S.T., et al. Characterization of Pseudomonas chlororaphis myovirus 201varphi2-1 via genomic sequencing, mass spectrometry, and electron microscopy. Virology 2008, 376:330.
169. Thomas J.A., Weintraub S.T., Wu W., Winkler D.C., Cheng N., Steven A.C., et al. Extensive proteolysis of head and inner body proteins by a morphogenetic protease in the giant Pseudomonas aeruginosa phage φKZ. Molecular Microbiology 2012, 84(2):324.
170. Trenina M.A., Akhverdian V.Z., Kolibaba L.G., Rebentish B.A., Krylov V.N. Features of genome expression of phage transposon D3112 of Pseudomonas aeruginosa in Escherichia coli bacteria: Dependence of bacterial phenotype on copy number of D3112 genome. Genetika 1991, 27:1324.
171. Uchiyama J., Rashel M., Takemura I., Kato S., Ujihara T., Muraoka A., et al. Genetic characterization of Pseudomonas aeruginosa bacteriophage KPP10. Archives of Virology 2012, 157:733.
172. Visca P., Chiarini F., Vetriani C., Mansi A., Serino L., Orsi N. Epidemiological typing of uropathogenic Pseudomonas aeruginosa strains from hospitalized patients. Journal of Hospital Infection 1991, 19:153.
173. Wang P.W., Chu L., Guttman D.S. Complete sequence and evolutionary genomic analysis of the Pseudomonas aeruginosa transposable bacteriophage D3112. Journal of Bacteriology 2004, 186:400.
174. Wang J., Hu B., Xu M., Yan Q., Liu S., Zhu X., et al. Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa. International Journal of Molecular Medicine 2006, 17:309.
175. Webb J.S., Lau M., Kjelleberg S. Bacteriophage and phenotypic variation in Pseudomonas aeruginosa biofilm development. Journal of Bacteriology 2004, 186(23):8066.
176. Williams B.J., Dehnbostel J., Blackwell T.S. Pseudomonas aeruginosa: Host defence in lung diseases. Respirology 2010, 15(7):1037.
177. Winstanley C., Langille M.G.I., Fothergill J.L., Kukavica-Ibrulj I., Paradis-Bleau C., Sanschagrin Fo, et al. Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa. Genome Research 2009, 13:12.
178. Wu W., Thomas J.A., Cheng N., Black L.W., Steven A.C. Bubblegrams reveal the inner body of bacteriophage φKZ. Science 2012, 335(6065):182.
179. Yacoby I., Bar H., Benhar I. Targeted drug-carrying bacteriophages as antibacterial nanomedicines. Antimicrobial Agents and Chemotherapy 2007, 51:2156.
180. Zegans M.E., Wagner J.C., Cady K.C., Murphy D.M., Hammond J.H., O'Toole G.A. Interaction between bacteriophage DMS3 and host CRISPR region inhibits group behaviors of Pseudomonas aeruginosa. Journal of Bacteriology 2009, 191:210.
181. Zemlyanaya N.Yu., Kozma A.R., Krylov V.N. Differences in mutator activity of phage-transposons of Pseudomonas aeruginosa. Genetika 1992, 28:160.
182. Zhang L., Sriprakash K.S., McMillan D., Gowardman J.R., Patel B., Rickard C.M. Microbiological pattern of arterial catheters in the intensive care unit. BMC Microbiology 2010, 10:266.